FindTrial
Sign In

Patient awareness survey on adverse events of glaucoma medications

Patient awareness survey on adverse events of glaucoma medications - Patient awareness survey on adverse events of glaucoma medications

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000040798
Enrollment
500
Registered
2020-06-17
Start date
2020-05-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Treatment with one glaucoma/ocular hypertension drug for at least 1 year at the time of participation in the study

Exclusion criteria

Exclusion criteria: Those have history of open surgery (including laser treatment) for glaucoma Those attending psychiatric or psychosomatic department Medical professinals (doctors, pharmacists, nurses, etc.) Those engaged in the manufacturing of pharmaceuticals and medical producsts Person engaged in drug marketing Those engaged in information provision services, research services and advertising

Design outcomes

Primary

MeasureTime frame
Psychological impact of adverse events Effects of adverse events on intention to continue instillation Effects of adverse events on intention to continue treatment—

Countries

Japan

Contacts

Public ContactKazunori Santo

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs

clinical@santen.co.jp06-4802-9603

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026